Sort
4,870 grants matching “glp 1”
A Novel Recombinant Protein Vaccine Against Ricin Toxin
$604,986Ellen S Vitetta · Ut Southwestern Medical Center · U01 · FY2006 · AI
Pharmacogenetics of the Response to a GLP1R Agonist
$604,825Amber L Beitelshees · University Of Maryland Baltimore · R01 · FY2025 · DK
The Weight-Independent Effects of Bariatric Surgeries on Islet Cell Function
$603,345Marzieh Salehi · University Of Texas Hlth Science Center · R01 · FY2019 · DK
Microtubule Regulation of Pancreatic Beta Cell Function and Diabetes
$603,100Irina Kaverina · Vanderbilt University · R01 · FY2024 · DK
High-Intensity Ultrasound Ablation for Septal Reduction Therapy of Hypertrophic Cardiomyopathy
$602,903Babak Nazer · Oregon Health & Science University · R01 · FY2022 · HL
Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier
$602,718Ana Krtolica · Omniox, Inc. · R01 · FY2017 · CA
EP055, a non-hormonal male contraceptive:IND-enabling studies
$602,521Michael G O'Rand · Eppin Pharma, Inc. · R44 · FY2022 · HD
A Randomized Controlled Trial of Exenatide as an Adjunct to Nicotine Patch for Smoking Cessation and Prevention of Post-Cessation Weight Gain
$602,358Luba Yammine · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · DA
Reversing Isoniazid Resistance By Isotopic Substitution
$601,735Graham S Timmins · Spinceutica, Inc. · R44 · FY2018 · AI
Multi-receptor Targeting of Glioblastoma
$601,671Waldemar Debinski · Wake Forest University Health Sciences · R01 · FY2024 · CA
Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas
$601,230Elias Sayour · University Of Florida · R37 · FY2024 · CA
Targeting timing of food intake as a novel strategy against disruption of blood pressure circadian rhythm in diabetes
$601,123Ming C Gong · University Of Kentucky · R01 · FY2021 · HL
Targeting timing of food intake as a novel strategy against disruption of blood pressure circadian rhythm in diabetes
$601,123Ming C Gong · University Of Kentucky · R01 · FY2022 · HL
Targeting timing of food intake as a novel strategy against disruption of blood pressure circadian rhythm in diabetes
$601,123Ming C Gong · University Of Kentucky · R01 · FY2020 · HL
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
$600,798Alexander V Kabanov · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Institute of Human Virology H3Africa Biorepository (I-HAB)
$600,000Alash'le G. Abimiku · Institute Of Human Virology · U24 · FY2021 · HG
PFI:BIC Bioengineering Glucagon-like Peptide 1 Analogs and a Formulation for Oral Delivery to Treat Diabetes
$599,683William W Bachovchin · Tufts University · · FY2013 · TIP
Iron Chelators Predicated on Desferrithiocin
$599,629Raymond J Bergeron · University Of Florida · R37 · FY2013 · DK
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)
$598,776Kristen J Nadeau · University Of Colorado Denver · R01 · FY2025 · HL
The thrombospondin1-TGF-beta axis in multiple myeloma
$598,327Joanne E Murphy-Ullrich · University Of Alabama At Birmingham · R01 · FY2018 · CA
The thrombospondin1-TGF-beta axis in multiple myeloma
$598,327Joanne E Murphy-Ullrich · University Of Alabama At Birmingham · R01 · FY2016 · CA
The thrombospondin1-TGF-beta axis in multiple myeloma
$598,327Joanne E Murphy-Ullrich · University Of Alabama At Birmingham · R01 · FY2015 · CA
The thrombospondin1-TGF-beta axis in multiple myeloma
$598,327Joanne E Murphy-Ullrich · University Of Alabama At Birmingham · R01 · FY2017 · CA
Project 3: Primary Prevention and Uterine Preservation in Premenopausal Women with Obesity and Endometrial Hyperplasia/Cancer
$596,971Andrea Hagemann · Washington University · P50 · FY2023 · CA
Metabolic effects of non-nutritive sweeteners
$596,781Kristina Rother · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK